Therefore, (i) the use of multiple species and paradigms to assess behaviors indicative of malaise and (ii) the separate administration of GIP and GLP-1 analogs in addition to tirzepatide were vital to resolving the clinical dichotomy discussed above. Here, GLP1R is linked to malaise.